Advertisement
Product Releases
Advertisement

Protein Analysis Biocolumns

Mon, 02/06/2012 - 3:30am

LISTED UNDER:

ZORBAX 300SB-C3Agilent Technologies Inc. announced it has expanded its family of sub-2 µm particle 300 Angstrom pore columns for reversed-phase liquid chromatography with ZORBAX 300SB-C3 and 300-Diphenyl 1.8 µm columns.

The columns extend the benefits of reversed-phase biomolecule separations to ultra-high-performance liquid chromatography (UHPLC). The C3 phase broadens the selectivity and improves peak shape and recovery options for larger proteins, including antibodies. The diphenyl phase offers additional selectivity through pi-pi interactions with aromatic amino acids in the primary structure.

The 1.8 µm particle size and 300 Angstrom pore size bring UHPLC efficiency, resolution, and quantitation to reversed-phase protein separations. Additionally, the columns are stable up to 1200 bar. Agilent's StableBond technology for the C18, C8, and C3 columns, and the end-capped diphenyl with Pursuit chemistry, deliver symmetrical peaks—even at low pH—when using trifluoroacetic or formic acid mobile phase modifiers. Column life is not compromised.

Agilent Technologies Inc., www.agilent.com

Advertisement

Share This Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading